z-logo
open-access-imgOpen Access
Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
Author(s) -
Chebib Nader,
Cottin Vincent,
TaharoAgRalissoum Martine,
Chuzeville Michel,
Mornex JeanFrançois
Publication year - 2018
Publication title -
pulmonary circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.791
H-Index - 40
ISSN - 2045-8940
DOI - 10.1177/2045893217753352
Subject(s) - medicine , treprostinil , sildenafil , ambrisentan , bosentan , iloprost , pulmonary hypertension , tadalafil , right ventricular hypertrophy , vascular resistance , intensive care medicine , prostacyclin , cardiology , hemodynamics , endothelin receptor , receptor
Nader Chebib, Vincent Cottin, Martine Taharo-Ag-Ralissoum, Michel Chuzeville and Jean-François Mornex Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Competence Center for Pulmonary Hypertension, Lyon, France; Claude Bernard Lyon 1 University, University of Lyon, Lyon, France; Hospices Civils de Lyon, Hôpital Edouard Herriot, Cardiogeriatrics Department, Lyon, France

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here